Skip to main content
Smart Investors Daily
AD

NASDAQ · ADUS

Addus HomeCare Corporation

Healthcare · Medical - Care Facilities

$126.29

Down-$1.95 (-1.55%)

Updated Nov 11, 2026, 5:15 PM

SID Score

6.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.91B
P/E ratio
19.91
Dividend yield
0.00%
52-week range
$87.95 – $131.59
Volume
225.85K
Avg. volume
212.6K

Price performance · ADUS

ADUS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 10, 2026

ADUS closed at $126.29 after 21 trading sessions, up 10.27% for the selected period.

Last close
$126.29
Period change
+10.27%
Period low
$114.53
Period high
$127.94
Daily close
View OHLC price history
ADUS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 10, 2026$121.88$126.62$121.45$126.29225.85K
Nov 9, 2026$124.71$127.49$121.83$122.42345.14K
Nov 6, 2026$124.59$125.91$123.64$124.31276.63K
Nov 5, 2026$128.86$131.59$125.71$126.81262.56K
Nov 4, 2026$121.03$130.40$120.22$127.94421.7K
Nov 3, 2026$126.00$127.08$124.15$126.55455.47K
Nov 2, 2026$125.54$127.06$123.06$125.75508.4K
Oct 30, 2026$125.65$126.62$124.45$125.54300.31K
Oct 29, 2026$124.61$125.50$122.565$124.34331.55K
Oct 28, 2026$121.15$123.07$120.03$122.18312.15K
Oct 27, 2026$121.37$122.13$120.51$121.24216.64K
Oct 26, 2026$122.34$123.4675$120.66$121.17202.75K
Oct 23, 2026$122.35$123.01$120.75$121.81224.26K
Oct 22, 2026$118.78$123.185$118.38$122.67147.48K
Oct 21, 2026$118.02$118.81$116.255$117.95163.6K
Oct 20, 2026$116.09$118.18$116.09$118.03138.92K
Oct 19, 2026$115.98$116.85$114.71$115.16130.41K
Oct 16, 2026$116.91$117.48$115.735$115.98136.89K
Oct 15, 2026$117.63$118.38$116.20$116.49172.42K
Oct 14, 2026$114.34$117.10$114.17$116.62249.67K
Oct 13, 2026$116.45$116.50$114.41$114.53145.6K

Latest ADUS news

The latest Smart Investors Daily articles mentioning ADUS.

ADUS research

Overview

Company profile and research snapshot.

Company profile

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$131.00
Implied upside
—
Analysts
—
ADUS recent ratings
DateFirmRatingTarget
Nov 5, 2026TD CowenBuy—
Nov 5, 2026Truist SecuritiesBuy—
Nov 5, 2026UBSBuy—
Nov 4, 2026BarclaysUnderweight—
Sep 14, 2026B of A SecuritiesNeutral—
Open full forecast

News briefing

Generated Nov 11, 2026, 3:01 PM

Why Is ADUS Down Today?

Addus HomeCare Corporation (ADUS) declined 1.87% today, falling $2.37 per share in a market where healthcare stocks are facing broader headwinds. The pullback appears connected to sector-wide weakness affecting medical service providers, as investors reassess valuations across the healthcare space.

    Bottom line: ADUS's modest 1.87% decline appears tied to sector-wide weakness in medical stocks rather than company-specific negative catalysts. Investors should monitor the company's ability to manage labor cost inflation while maintaining margins, and watch for updates on reimbursement rates and acquisition strategy at the next earnings report.

    Yahoo · Nov 6, 2026

    Should Value Investors Buy Addus HomeCare (ADUS) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.